Skip to main content

Breathalyzers Market Development Analysis Contributing Top Vendor Landscape and Economic Growth 2028

 


The breathalyzer market refers to the sales and distribution of devices used for measuring blood alcohol content (BAC) through analysis of a breath sample. These devices are widely used by law enforcement agencies for detecting drunk drivers and in workplaces for alcohol screening. The market has been growing due to increasing awareness about the dangers of drunk driving, stricter laws and penalties, and advancements in technology that have made breathalyzers more portable and user-friendly. The market is expected to continue growing in the future as demand for personal and professional use breathalyzers increases.

Breathalyzers are instruments used for testing blood alcohol levels through an individual’s breath. These devices find application in probation departments, police departments, remand homes, and commercial sector.

The global breathalyzers market is estimated to account for US$ 6,384.5 Mn in terms of value in 2020 and is expected to reach US$ 71,866.2 Mn by the end of 2027.

 

Labels:

Comments

Post a Comment

Popular posts from this blog

Fc Protein and Glycoengineered Antibodies Market Is Booming Worldwide 2023-2028

  Global Fc Protein and Glycoengineered Antibodies Market Drivers Key players in the market are focusing on research and development activities and receiving approvals from regulatory bodies, which are expected to boost the global Fc protein and glycoengineered antibodies market growth over the forecast period. For instance, in 2016, Genentech Inc. received approval from the U.S. Food and drug Administration (U.S. FDA) for Tecentriq (Atezolizumab). It is being used for the treatment of urothelial carcinoma. In March 2019, Tecentriq received its second approval from the U.S. FDA for the treatment of small lung cancer. Furthermore, in November 2017, TG Therapeutics, Inc. began its clinical trial of Ublituximab for the treatment of multiple sclerosis. It is currently in third phase of its clinical trial. Factors such as increasing product approvals and robust pipeline are expected to drive the global fc protein and glycoengineered antibodies market growth.  Increasing preva...
Post a Comment
Read more

Increasing Incidences of Infectious Diseases to Augment the Antibacterial Drugs Market Growth

  Antibacterial drugs are widely used to treat and prevent infectious diseases and are categorized into seven major classes, such as β-Lactams, phenicols, macrolides, quinolones, sulfonamides, tetracyclines, and aminoglycosides, based on their molecular structure. Antibacterial drugs destroy or slow down the growth of bacteria. These medications are also used to treat urinary infections caused by S. aureus, E. coli, Streptococcus pyogenes, and other bacterial infections. They include a range of powerful drugs used to treat diseases caused by bacteria. Antibiotics cannot treat viral infections, such as cold, flu, and most coughs. Antibacterial drugs play a major role in advanced healthcare, as they are widely used to treat infectious diseases, such as tuberculosis, malaria, typhoid, leprosy, hepatitis B, HIV/AIDS, and others. Thus, there is an increasing demand for antibacterial drugs worldwide.  
Post a Comment
Read more